San Raffaele Telethon Institute for Gene Therapy · company speakers →
Dr. Naldini will review progress that his laboratory is making in the development of an autologous gene edited hematopoietic stem cell therapy for X-linked severe combined immunodeficiency.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →